National Brain Tumor Society

The National Comprehensive Cancer Network® (NCCN®) believes the best management of any patient with cancer is a clinical trial, but the idea of enrolling in a clinical trial may seem daunting. In this video, hear why Julio Piña, a patient with anaplastic ependymoma, and his wife Liz enrolled in a trial and what the process looked like. Learn more about clinical trials through NBTS’s MyTumorID campaign, and sign up to receive the latest news about clinical trials, biomarker testing, and more: https://lnkd.in/gKBnUW4u #ClinicalTrials #MyTumorID #NationalBrainTumorSociety

NBTS has spots available in the Medtronic Twin Cities 10-Mile! Explore the picturesque course from Minneapolis to Saint Paul, across the mighty Mississippi River to the Minnesota capitol. Join our #GrayNationEndurance team to put meaning behind your miles this October! Apply today: https://lnkd.in/eaxaUwNk

Anang Shelat, PhD, talks about why it’s important to have pediatric representation to evaluate drug compounds more efficiently. Anang and two fellow researchers at St. Jude Children's Research Hospital are focusing on the toughest types of pediatric brain tumors — DIPG/DMG, AT/RT, and childhood ependymomas — as part of NBTS’s DNA Damage Response Consortium. #CCAM #ChildhoodCancerAwarenessMonth

Returning to school after a #pediatricbraintumor diagnosis can feel overwhelming. 🎒Our latest blog post is filled with actionable tips to ease the transition, from involving the school early to fostering connections with classmates even during treatment to requesting reasonable accommodations. Check out these actionable tips for your child’s school re-entry: https://lnkd.in/eyR9MFwB #CCAM #ChildhoodCancerAwarenessMonth

The 2024 Virginia Brain Tumor Walk & Race will take place at a brand new location this November 3 at Bryan Park in Richmond! Bryan Park offers a certified 5K loop course through scenic trails, with plenty of parking and play areas for the kids, as well as several local food and beverage trucks. The Virginia #braintumor community needs your help in achieving our mission of conquering and curing brain tumors –– once and for all. Register TODAY at: https://lnkd.in/g5Q83JbE #VirginiaBTWalkRace #braintumorfundraiser #braintumorevents #NationalBrainTumorSociety

Brain and other CNS tumors are the most common form of solid cancer in children in the U.S. Help us raise awareness about pediatric brain tumors by sharing your story this September during Childhood Cancer Awareness Month. As a thank you for submitting your story, you’ll be entered for a chance to win an NBTS giveaway bag. Tell us your story today: https://lnkd.in/ekRsEM5a #ChildhoodCancerAwarenessMonth #CCAM

The Brain Tumor Investment Fund (BTIF) is pleased to welcome EnClear Therapies to our investment portfolio! EnClear is pioneering solutions for central nervous system (CNS) diseases through innovative neurotechnological strategies. In development as their flagship product is the EnTrega CSF Management Platform. EnTrega is a novel system designed to deliver therapies into the cerebrospinal fluid (CSF), and via proprietary software, optimize therapeutic residence time and drug distribution, potentially improving outcomes in a variety of CNS diseases, including brain tumors. The system will feature non-invasive patient monitoring, machine learning-enhanced safety protocols, and automated CSF sampling. BTIF is joined in this investment by the Sontag Innovation Fund, Amgen Ventures, and other investors with interest in advancing drug and device development for patients with brain tumors and other CNS diseases. Join BTIF in welcoming EnClear Therapies to the portfolio and please see the press release here: https://lnkd.in/g8ifqkZu #braintumors  #conquercancer  #glioblastoma  #brainmets #neurooncology  #NationalBrainTumorSociety  #BrainTumorInvestmentFund 

Pediatric patients with a brain tumor need more — more research, more treatments, and more time. This #CCAM, make a gift to accelerate NBTS’s work as we drive change for pediatric patients and their loved ones, invest in promising treatments to achieve life-saving outcomes, and foster community nationwide. Together, we can break down barriers today and forge opportunities to transform pediatric brain tumor research and health care for the future! Give today: BrainTumor.org/CCAM #ChildhoodCancerAwarenessMonth

Thank you Anang Shelat for being a part of National Brain Tumor Society's DNA Damage Response Consortium that is bringing forward a new class of promising treatments to confront the toughest pediatric brain tumors and showcase team science in the process. https://lnkd.in/ezwDG5TJ #CCAM #ChildhoodCancerAwarenessMonth

As #braintumors are the leading cause of cancer-related death and the most commonly diagnosed form of solid tumors in children and adolescents age 19 and younger, the #braintumor community has an enormous stake and voice in #ChildhoodCancerAwarenessMonth. This #CCAM, share quick, impactful stats about #pediatricbraintumors to raise public awareness and inspire others to take action: BrainTumor.org/CCAM